News

Deal Announcements

Coronado Biosciences Adds $26 Million New VC

Thursday, July 7, 2011 5:33:00 AM PDT | VentureDeal Staff
   New York, New York  --  Cancer biotechnology company Coronado Biosciences has raised $25.8 million in new venture capital investment, according to an SEC regulatory filing.

Coronado is focused on treatments that will make cancer and inflammatory disease care safer and more easily tolerated with improved outcomes.

Investors in the financing were not disclosed. The company is still seeking an additional $2.9 million in funding.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1